Back to results
US 2008/0167571 A1Published application
Determination of treatment results prior to treatment or after few treatment events
OwnerAlan Gevinsinventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerAlan Gevinsinventor
Estimating the term…
Disclosed are methods and data on determining response to a drug or other therapy prior to administration by obtaining a direct neurocognitive brain function measurement; obtaining an indirect neurocognitive brain function measurement; and, assessing the direct neurocognitive brain function measurement and the indirect neurocognitive brain function measurement collectively to obtain a response determination preferably the predictive value of the collective assessment is greater than a predictive value obtained from the separate predictive values for the direct and indirect measurements. Also disclosed are methods of determining dosage of a drug comprising administering a drug; comprising obtaining a direct neurocognitive brain function measurement; obtaining an indirect neurocognitive brain function measurement; and, assessing the direct neurocognitive brain function measurement and the indirect neurocognitive brain function measurement collectively to obtain a dosage, preferably the predictive value of the collective assessment is greater than a predictive value obtained from the separate predictive values for the direct and indirect measurements; optionally, additional cycles of obtaining and assessing indirect and direct measurements are performed.
A method of predicting response to a drug prior to drug administration comprising:
A method of determining dosage of a drug with a linear dose-response curve, comprising steps of:
A method of determining dosage of a drug with a nonlinear dose-response curve to achieve a specified response, comprising steps of:
A method of detecting mild cognitive impairment (“MCI”), comprising steps of:
Dependencies are inferred from the claim text.